| Factor Information | |
|---|---|
| Data ID | 753 |
| Factor | NT-proBNP level |
| Description | N/A |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the predictor of adverse cardiac events |
| p Value | <0.001 |
| Conclusion | The most significant predictor of adverse cardiac events in patients with complex CHD was NT-proBNP level. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 481 |
| CHD Type | isolated CHD |
| CHD Subtype | CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
| Reference | |
|---|---|
| PMID | 28886170 |
| Year | 2017 |
| Title | Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease? |
| Sample | ||
|---|---|---|
| Population | adolescent and adult | |
| Source | data | |
| Region | Germany | |
| Method | ROC curve analysis | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | cardiac operation | |
| Group | patients with adverse event(Treatment) | patients without adverse event(Control) |
| Number | 30 | 113 |
| Age | 31.1±15.5 years | 26.5±10.8 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 651.0 (275.1-1326.2) pg/mL | 136.7(68.9-275.8) pg/mL |
